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1. Introduction 
Catheters are used for effective drainage of the bladder, either temporally or permanently, 
in the presence of physiological and anatomical defects or obstruction of the lower urinary 
tract. Catheters are used for a variety of reasons, as follows, to maintain bladder drainage 
during and following surgery or epidurals anesthesia for minimizing and prevention of the 
risk of distension injuries;  investigations, for accurate urine output measurement, and 
measurement of post-micturition residuals; treatments, to relieve urinary retention or for 
chemotherapy instillation; intractable incontinence, as the final option for containment. 
2. Urethral catheterization 
Urethral catheterization is a routine medical procedure that allows direct drainage of the 
urinary bladder into an attached bag or container. It consists in the insertion of a catheter 
into a patient's bladder.  
Urinary catheterization is employed in hospital and nursing home settings to maintain urine 
output in patients who are undergoing surgery, or who are confined to the bed and 
physically unable to use a bedpan. Critically ill patients who require strict monitoring of the 
urinary output are also frequently catheterized. Urethral catheterization may be performed 
as either a therapeutic or a diagnostic procedure. Therapeutically, catheters may be placed 
to decompress the bladder in patients with acute or chronic urinary retention. In addition, 
catheters may be placed to facilitate bladder irrigation in patients with gross hematuria. 
Diagnostically, urinary catheters may be placed to obtain an uncontaminated urine sample 
for microbiologic testing, to measure urinary output in critically ill patients or during 
surgical procedures, or to measure post-void residuals. The only absolute contraindication 
to urethral catheterization is known or suspected urethral injury, usually in the setting of a 
pelvic fracture. 
Surely these interventions were performed already long time before recorded history. 
Although in the most ancient medical writings, such the code of Hammurabi -1700 B.C.- (1), 
there is no clear mention of catheterism, the condition of urinary retention is well described 
in an ancient Chinese medical text, the Huang Ti Nei Chingh Su Wen (mentioned in the 
Annals of the Former Han Dinasty- 206 B.C. to 25 A.C., but referred to a much earlier 
origin). It is a sort of dialogue where the emperor (Huang Ti) poses questions to a minister, 
whose answers convey a clear sense of organ-based pathology: “(…) When the bladder does 
not function efficiently, it causes retention of urine; when it functions without restraint, it 
causes copious urination” (2). If urinary retention was so specifically identified and 
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described, it is likely that it was treated with catheterization: the technology was available. 
For instance, hollow leaves of Allium Fistolosum, an onion plant, coated with laquer, were 
used as catheters in China around 100 B.C (3). The Sushruta Samhita, an early Indian 
surgical text dated approximately around 1000 B.C: describes tubes of gold, silver, iron and 
wood smeared with ghee (liquid butter) for evacuation of urine, management of strictures, 
instillation of medication and for assistance in lithotomy. Sushruta suggest also that “wine 
should be used before operation to produce insensibility to pain” (4).  
Urethral catheterization is then always well described among the medical writings of the 
first millennium and the Renaissance, even if it was not even mentioned by one of the most 
famous scientists ever, Leonardo da Vinci. During this period the main factor driving the 
need for diagnostic and therapeutic catheterization was the bladder stone. Even Benjamin 
Franklin, in a letter written on December 8th, 1752, described a flexible silver catheter he 
designed for his older brother John, who suffered from bladder stone. This device was made 
from a flat silver wire, wound spirally and then covered with waxed threadbound 
parchment (5). In 1756 Heuermann provided a good description of catheter therapy for 
benign prostatic hypertrophy, and during the next 150 years, according to Laurisden, this 
method was “absolutely Paramount” (6). 
Industrialization brought about the manufacturing ability to make better surgical 
instruments as well as the scientific means to fit the tool to the task: the configuration of the 
catheter was investigated by anatomical studies, and the designs of past millennia were for 
the most part found appropriate. The Goodyear patent for moldable hard rubber in 1851 
permitted faster and cheaper production of catheters: Auguste Nelaton, physician to 
Napoleon III, introduced a flexible rubber catheter in 1860 (7). Mercier the coudé catheter in 
1836 and the bicoudé in approximately 1841, with one or two bends near the tip 
respectively. By the late 19th century a wide armamentarium of catheters was available to 
the practitioner. George Tiemann’s catalogue of surgical instruments listed nearly 80 
different types of catheters. Special types were used for various purposes in cases of urethral 
strictures, stones or foreign bodies, and for evacuation of urinary retention, irrigating and 
distending the bladder (8). The development of the balloon catheter has been documented 
by Zorgniotti, who traced it back to Reybard’s device in 1853. Foley (1891 to 1966), an 
ingenious American urologist, devised a balloon catheter for haemostatis in prostatic 
surgery (9). He demonstrated the first production model at the annual meeting of the AUA 
in 1935. Although a different company (the Davol Rubber Company) retained the rights to 
the balloon catheter after applying a key patent five months later, the “Foley” name has 
become universally synonymous of self-retaining balloon catheter. 
By these times, lacking the scientific justification of the germ theory, medical practitioners, 
except for a few ones, had little interest in cleanliness around wounds. Joseph Lister 
experimented with urine putrefaction, and found out that was normally sterile and had an 
uncanny sense of host resistance (10). After his studies and the similar ones performed by 
Roberts, clean techniques and antiseptic principles became standard practice, and urethral 
catheterization thereby achieved another degree of safety (11).  
3. Diagnostic uses 
Bladder catheterization facilitates obtaining a specimen for urinalysis or culture (e.g. in 
children), measuring post-void residual volume, and undertaking more extensive 
urodynamic studies to diagnose causes of urinary incontinence. Radiographic contrast may 
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be instilled through a catheter to visualize bladder or urethral pathology, and document 
vesicoureteric reflux. The bladder may be distended with a saline solution to form a 
sonoluscent structure, prior to a pelvic ultrasound. 
4. Short-term (0-2 weeks) or intermediate term (2-6 weeks) therapeutic uses 
Indwelling catheters are used during labor following epidural anesthesia, and in the fluid 
management and tocolysis of patients with pre-eclampsia and eclampsia. An empty bladder 
facilitates pelvic dissection in patients undergoing hip and abdominopelvic surgical 
procedures. Moreover urethral catheterization enables measurement of intra- and post-
operative urine output and eases post-procedure patient care. Intermittent or short-term 
catheterization may be helpful in treating bladder neoplasms (Cytotoxic drugs and BCG 
may be administered intravesically), and mycotic infections (Amphotericin in fungal 
cystitis). 
Surely the primary care of any patient with acute urinary retention (that may arise from a 
variety of causes) is urethral catheterization: temporary decompression of the bladder 
through an indwelling catheter may be necessary until resolution of the primary cause of the 
retention.  
Short term or intermittent catheterization may be required following urethropexy or a sling 
procedure for bladder neck obstruction, when swelling and pain may cause retention. Other 
organic causes of obstructed voiding in women (neoplastic, inflammatory) may also be 
managed with clean intermittent or indwelling catheter drainage until the underlying 
condition is treated. Incomplete pelvic floor relaxation with resulting dysfunctional voiding 
may also be treated with catheterization. 
Gluteal, sacral or trochanteric skin trauma or decubitus ulcers contaminated by urine in an 
incontinent patient will respond to temporary urinary diversion through catheterization to 
maintain a moist and infection-free environment.11 
5. Long-term therapeutic uses (> 6 weeks) 
In selected cases of urinary incontinence not responding to conservative treatments Clean 
Intermittent Catheterization (CIC) may be carried out. This will maintain mobility and renal 
function, and minimize residual urine, infectious complications and calculus disease. In this 
setting another application of CIC is represented by the presence of a poorly contractile 
bladder that is usually unresponsive to behavioral or pharmacologic therapy. Surgery is 
generally not indicated for men with this condition, and in most cases, patients are required 
to perform CIC. 
During the last ten years CIC has become the standard care in patients with spinal cord 
injuries. Continuous or intermittent catheterization should be established immediately in a 
hypotonic bladder to prevent over-distention, infection and detrusor muscle damage. 
Spastic bladder following spinal injury may require condom catheter or long-term 
suprapubic drainage. In these cases CIC or continuous bladder drainage may also be helpful 
for incontinent patients, immobile subjects due to aging or finally in cases of terminal illness. 
However, continuous drainage should be used rarely, and only as a last resort. 
6. Catheter characteristics 
Urethral catheterization is the most frequent retrograde manipulation performed on the 
urinary tract. Catheters are placed to drain the bladder during and after surgical procedures, 
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to assess urinary output in critically ill patients, to collect reliable urine specimen and to 
assess post voiding residual urine. Such catheters can be left indwelling with a self-retaining 
balloon or used for clean intermittent catheterization procedure.   
The choice of a specific type of catheter depends upon the reasoning of catheterization. 
Large-caliber catheters are used to evacuate potential blood clots or to assess urinary output. 
Other catheter variables include balloon size and construction materials. In this way large 
balloons can be inflated to help hemostasis after transurethral resection of the prostate or in 
case of open prostatectomy. Sometimes the standard latex catheter can result in severe 
reactions in patients with latex allergies and silicone varieties are good alternatives in such 
situations. In particular the silicone catheters are usually manufactured with several grooves 
placed on the surface of catheter itself to allow an interface between the catheters and the 
urethra and thus avoiding the possibility of infection in the short term (1). Therefore the 
catheters can be distinguished by the shape of the tip, the characteristics, the diameter, the 
number of ways and the materials. 
Straight rubber or latex catheters often referred to as Robinson catheters, are straight 
catheters used for short-term catheterization, as in measurement of residual urine and 
instillation of medication chemotherapeutic agents or in case of radiological evaluation of 
the bladder. The tip of the Robinson catheter is rounded, with one or two drainage ports 
along the side. Self-retaining catheters like the Pezzer and Malecot catheters, are shaped in 
such a way that after placement at open surgery the catheter configuration maintains the 
catheter within a hollow viscus (Fig.1a). The advantage of these catheters include the 
excellent urinary drainage and the tip design, which make them ideal for use as cystostomy 
or nefrostomy tubes. Foley-types catheters are most often used for long-term urethral 
catheterization.  
The catheters are often named according to the characteristics of the proximal tip as follows: 
1. The Nelaton catheter is the standard catheter and has a rounded and straight proximal 
end. It has two lateral eyes for drainage (Fig.1b).  
2. The Mercier catheter has a rounded and angular (30-45°) tip. The angle helps the 
introduction of the catheter in the membranous or prostatic urethra (Fig.1c).  
3. The Tiemann catheter can have a cone shaped tip, which can be straight (olive-tip 
catheter) or angular (Fig.1d). 
4. Couvelaire catheter is used in case of bladder hemorrhage or after a urologic surgical 
intervention because it guarantees an efficient drainage. The structure can be rigid or 
semi-rigid and it has one drainage eye at the end and two lateral eyes (Fig.1e). 
5. Dufour catheter (semi-rigid, self-retaining) has three ways. The tip has a 30° curve, is 
open and with two staggered drainage eyes. It is used in case of gross haematuria 
(Fig.1f).   
External diameter is sized by Charrièr (1CH=1/3mm). The size of the catheter is selected 
according to specific clinical use. The length of catheter is usually 420mm for male, 260mm 
for female and a shorter for pediatric patients.  In clinical use the size of the catheter should 
guarantee a safe urine drainage without damaging the urethral mucosa and avoiding 
infections, stricture or scarring causing stenosis. The use of smaller than 14Ch is 
recommended in contrast with large catheter that increases the risk of blockage of 
paraurethral glands causing urethritis or other ascending infection. Silicon or silicon-coated 
catheters produce less tissue reaction and less encrustation than rubber catheters(2). They 
also have a larger lumen diameter than catheters made of rubber and thus are preferred by 
some for long-term indwelling catheterization.  
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Fig. 1. Types of urinary catheters : a) Pezzer self-retaining catheter; b) Nelaton catheter; c) 
Mercier catheter; d) Tiemann catheter; e) Couvelaire catheter; f) Dufour catheter. 
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Catheters can have one, two or three ways. In two ways catheters, one way provides urine 
drainage, the other way which is provided with a valve allows the inflation of a balloon that 
is inserted in the bladder to keep the catheter securely in place. Three-way catheters have a 
small lumen inflating the balloon mechanism, a lumen for instilling irrigant and a larger 
lumen for bladder drainage. Silicone, PVC and latex are the most used materials to produce 
catheters. Latex and PVC are mostly used for short-term catheters or in intermittent 
catheterization. Silicone is more used for long-term catheters because it is considered to be 
biocompatible and it is recommended for patients who are allergic to latex. Different 
catheter surfaces, such as latex, silicone, or Teflon, have not been shown to alter the 
frequency of urinary infection. Silicone catheters may be less likely to become blocked by 
encrustations due to prolonged use (3,4). In this way it seems to be evident that the use of 
silicone catheters are less prone to infections. Thus, silicone catheters, which tend to be more 
expensive, should be reserved for residents shown to have a consistent problem with 
repeated catheter obstruction. In this context P aeruginosa had a higher rate of adherence to 
Teflon or silicon catheters than other gram-negative species. (5) Conflicting results 
describing the effectiveness of antimicrobial-coated catheters, including silver-coated 
catheters, in preventing infection for short-term catheters have been reported. These 
materials are likely to be less effective for long-term catheters, because duration of catheter 
use is such an overwhelming determinant for infection. Catheters available today have a 
roughly engineered surface that is extremely vulnerable to blockage by crystalline biofilms 
and therefore we hope that in the future new biomaterials, which limit biofilm formation, 
will be developed. 
7. Urethral catheter and related infections 
7.1 Epidemiology 
The catheterization is widely used to relieve anatomic or physiologic obstructions, to 
provide a dry environment for comatose or incontinent patients, and to permit the accurate 
measurement of urine output in severely ill patients. Unfortunately, when catheters are used 
inappropriately or when left in place too long they increase the risk of asymptomatic 
bacteriuria and urinary tract infection (UTI). The catheter-associated urinary infections 
(CAUTIs) have been reported to increase mortality and have a considerable economic 
impact. For these reasons catheter should be removed as soon as possible in order to prevent 
the risk of infection. Urinary tract infections account for 20 to 40% of hospital-associated 
infections, and an estimated 80% are associated with urinary catheter. The majority of 
studies say that 10 to 30% of people who are catheterized for a short period develop 
bacteriuria (often asymptomatic) and that after 30 days of catheterization bacteria can be 
found in the urine of all patients. The infections provoked by the use of a short-term catheter 
may prolong hospitalization by 2.4 to 4.5 days, and are likely to be associated to an increase 
in nosocomial mortality. Asymptomatic bacteriuria converts to symptomatic in 
approximately 24% of patients(7). Long-term urinary catheters are a leading cause of 
morbidity in acute care settings, accounting for up to 40% of hospital-associated infections 
(8,9). Within the hospital environment, the intensive care unit has the highest prevalence of 
nosocomial infections with estimated rates of 8–21% for nosocomial UTI of which 95% are 
catheter-associated(10). The daily incidence of bacteriuria in catheterized patients is 
approximately 3–10%. Among patients with bacteriuria, up to 25% will develop symptoms 
of local UTI, and about 3% will develop bacteremia (11). Catheter-associated UTI is the 
www.intechopen.com
 Catheters and Infections 
 
89 
second most common cause of nosocomial bloodstream infection. Patients who develop 
nosocomial UTI have their hospital stay extended by approximately 3 days and are nearly 
three times more likely to die during hospitalization than patients without such an infection. 
The case-fatality rate from UTI-associated bacteremia is approximately 13% within severely 
ill patients at highest risk (12,13).   
It Deserves a mention the CIC has emerged as the most practical to ménage urinary 
emptying dysfunction and reduces significant lower urinary tract infection. CIC has been 
effective in managing patients with spinal cord injury, diabetes, multiple sclerosis, outlet 
obstruction and continent urinary diversion. This management technique is not without 
complications, including urethral trauma, increased urinary infection, stone disease and 
even progression of the upper urinary tract deterioration that the management technique is 
attempting to prevent. A controversy has surrounded the concept of CIC vs. sterile 
technique from the beginning of its use. Regarding bacteriology and urinary tract infections 
and even for CIC most authors conclude that in the still existing light of many controversies 
in bacteriology and management of infections, CIC is an acceptable way of voiding a 
neuropathic bladder, enabling a voluntarily induced balanced micturition within a shorter 
period of bladder training, having less aggressive urinary tract infections by reducing the 
residual urine volume and last but not least assisting continence and avoiding unaesthetic 
leg-bags, aggressive indwelling catheters or irritating external urine collecting devices such 
as diapers. In his publication Kuhn observe that after CIC, in 13 out of 46 patients (28%) the 
type of bacteria in the urine did not change from that of the first bacteriological control. 
Antibiotic prophylaxis is probably ineffective in preventing symptomatic urinary tract 
infections. Recent Cochrane library reviews conclude that the current strength of evidence is 
weak and well-designed studies are strongly recommended. Based on the current evidence, 
it is not possible to state that any catheter type, technique or strategy of self-catheterization 
is better than another in prevention of infections. The sterile versus clean technique question 
is of relatively low importance because in community settings (where most IC takes place) a 
sterile technique is not practical. In hospital settings rising concerns about infection control 
indicate that a sterile technique would be needed for safety (14,15)  In any case intermittent 
catheterization is a commonly recommended procedure for people with incomplete bladder 
emptying not satisfactorily managed by other methods. 
7.2 Pathogenesis 
Indwelling urinary catheters are used for short-term (<14 days mainly in hospitals) and 
long-term (>30 days mainly in nursing homes and home care) urinary drainage (16). Short-
term catheterization usually results in bacteriuria that rapidly clears after removal of the 
catheter, especially with antibiotic therapy. Symptomatic urinary infection or febrile 
episodes are more commonly associated with long-term catheterization. An indwelling 
catheter impairs normal host defenses both by promoting increased access of 
microorganisms to the bladder and by compromising complete voiding. Generally, infection 
is introduced via two routes after catheterization: the intraluminal route via the inside 
lumen of the catheter, or the trans-urethral route between the catheter and the urethra. The 
infections that arise with catheterization are caused by bacteria from patient’s body or 
colonic flora and by bacteria found in the hospital setting. Bacteria can invade the lower 
urinary tract along the surface of the catheter or by its lumen. Bacteriuria that occurs during 
short-term catheterization is usually caused by a single organism. The most commonly 
isolated pathogen its Escherichia-coli and enterococci, pseudomonas, enterobacter, staphylococcus 
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aureus or epidermidis, klebsiella and serratia. In the long-term catheterization common 
urophatogens include Escherichia-coli, Pseudomonas aeruginosa and proteus mirabilis(17,18). 
Many of these pathogens develop a multiple antibiotic resistance and they could adhere to 
the catheter surface, in these case the catheter becomes a reservoir for the pathogens. The 
reason why bacteria migrate through the catheter into the bladder without being expelled 
by the urine is still not clear. Urine has a cleaning action that protects the bladder from 
backwards invasion of skin pathogens, which is why healthy subjects do not get an infection 
if bacteria is injected in the bladder. Most probably the reason why bacteria are not expelled 
in UTIs associated with catheterization is the adhesion of bacteria to the bladder urothelium. 
Epithelial cells in the bladder usually are coated with Lactobacillus that are not invasive nor 
virulent but can prevent virulent organisms from sticking to the bladder wall (19). When the 
coat of the cells is missing, colonization of bacteria and infections of the lower urinary tract 
begin. The mechanism is therefore strictly related to the adhesion of bacteria to the bladder 
during catheterization. Analysis with electron microscope of the surface of catheters show 
that indwelling catheters are rapidly colonized by a thick layer of microorganisms included 
in a protein matrix of the host, and by polysaccharides produced by bacteria that form a 
biofilm (20).  
The risk of urinary tract infection is related to the length of time that the catheter is in place. 
Most patients catheterized for a week or less should escape infection, but for the elderly and 
disabled patients who are catheterized for several months or years, bacteriuria is inevitable 
(21). Risk factors other than the duration of catheterization include contamination of the 
drainage-bag, diabetes mellitus, female patient, antibiotic usage and a compromised status 
of renal function. The risk of CAUTIs is increased in patients who are in urinary retention, in 
patients catheterized peripartum, in debilitated patients (22). In this case organisms that 
colonize the periurethral skin can migrate into the bladder through the mucoid film that 
forms between the epithelial surface of the urethra and the catheter. In addition, 
contamination of the urine in the drainage bag can allow organisms to access the bladder 
through the drainage tube and the catheter lumen (23). The initial bacteria that cause the 
urinary tract infections are usually Staphylococcus epidermidis, Escherichia coli or Enterococcus 
faecalis. As time goes by, other species appear in the residual bladder urine, including 
Pseudomonas aeruginosa, Proteus mirabilis, Providencia stuartii, Morganella morganii and 
Klebsiella pneumoniae.(8,23).  Biofilms containing 5 × 109 viable cells per centimeter can be 
found on long-term indwelling catheters removed from patients.(20) The biofilm 
populations, therefore are often outnumber than those in the urine. The most common 
species present in the mixed-population biofilms are E. faecalis, P. aeruginosa, E. coli, and P. 
mirabilis. The biofilms formed are generally sparse, and because the catheter is removed 
within a few days, they cause few problems. By contrast, long-term catheters become 
colonized by extensive biofilms, which can have profound effects on the health of the 
patient. By far the most troublesome biofilms are those that become crystalline in nature 
(24,25). These biofilms may be present on the outer surface of the catheter around the 
balloon and catheter tip, and can cause trauma to the bladder and urethral epithelia. The 
crystalline deposits on catheters have a similar composition to infection-induced kidney and 
bladder stones. Struvite (magnesium ammonium phosphate) and a poorly crystalline form 
of apatite (a hydroxylated calcium phosphate, in which a variable proportion of the 
phosphate groups are replaced by carbonate) are the principle crystalline components 
(23,26). Urease is the driving force of crystallization: it hydrolyzes urea, leading to the 
formation of ammonium and carbonate ions and an increase in urinary pH. As the urine 
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becomes alkaline, magnesium and calcium phosphate crystals are precipitated. Aggregates 
of this crystalline material accumulate in the urine and in the biofilm that develops on the 
catheter surfaces. The continued accumulation of crystalline bacterial biofilm blocks the flow 
of urine through the catheter (2) causing bladder over-distension and damaging the 
urothelium aiding the attachment of bacteria to epithelial surface. P. mirabilis is not usually a 
pioneer colonizer of the catheterized urinary tract, and is not commonly found in patients 
undergoing short-term catheterization(26). P. mirabilis is considered to be an ingenious 
organism capable of initiating crystalline biofilms. Microorganisms that grow in biofilm are 
less likely to respond to antibiotic treatments. The majority of catheters removed within the 
seventh day of catheterization are already colonized by a bacterial biofilm. The presence of a 
urinary catheter impairs the normal protective mechanisms of the bladder. The duration of 
catheterization is the important factor of bacteriuria (27) but important risk factors are also 
the microbial colonization of the periurethral area and perineum providing a route for 
bacterial entry along both the internal and the external surfaces. In addition, urine often 
pools in the bladder or in the catheter itself and urinary stasis encourages bacterial 
multiplication.  
8. Fungal urinary tract infections 
Fungal urinary tract infections (funguria) are rare in community medicine, but common in 
hospitals where 10 to 30% of urine cultures isolate Candida species Funguria, or candiduria, 
may develop as early as the first 2 weeks of hospitalization. An indwelling urinary catheter 
is a known risk factor for funguria. Candida albicans is the most commonly isolated fungal 
species (40–65%) from the urine, but other species such as Candida glabrata and Candida 
tropicalis, also may occur. Candida as well as staphylococci can reach the hub site via the 
hands of health personal (26) . Non-pharmacologic measures, such as removing unnecessary 
antibiotics, and removing the urinary catheter, are typically beneficial but generally 
inadequate without additional pharmacologic therapy. The most serious complication of 
untreated asymptomatic funguria is candidemia, which occurs in less than 10% of cases. 
(28).  
8.1 Diagnosis 
Patients with CAUTIs are usually asymptomatic. The presence of bacteria in the urine does 
trigger an inflammatory response in terms of pyuria and urinary interleukins. The most 
common presentation of symptomatic infection is fever often associated with haematuria. 
Symptomatic bacteriuria is characterized by the presence of dysuria, urgency, frequency and 
hematuria (28). Symptomatic UTI occurs when bacteriuria leads to either local symptoms of 
infection, or systemic symptoms. Urinary catheter-related bacteremia is diagnosed when the 
same organism is isolated from both the urine and the blood cultures in the absence of other 
likely sources of infection. The risk of asymptomatic bacteriuria to bacteremia conversion is 
approximately 3–4%, and the estimated attributable mortality of urinary tract-related 
bacteremia is approximately 13%. Catheter associated UTI is diagnosed at a lower level of 
bacteriuria (>102 or >103 CFU/ml) for asymptomatic infections, plus associated symptoms 
for the symptomatic infections (29,30).  The wide spectrum of potential infecting organism 
and increased likelihood of resistance means microbiological confirmation of the infecting 
organism and susceptibility testing are essential for determining optimal therapy. A positive 
urine culture supports a diagnosis of UTI but it is not sufficient to distinguish symptomatic 
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from asymptomatic infection. Thus, urine culture result must always be interpreted in the 
clinical context. In patients with short term indwelling catheter the specimen should be 
obtained by sampling through the catheter port. In patients with chronic indwelling catheter 
the preferred specimen is obtained from a new catheter placed immediately prior to 
initiating antimicrobial therapy (26). The urine specimen obtained through the new placed 
catheter reflects the bacteriology of the urine, rather than the biofilm.   
9. Prevention and treatment of catheter-associated urinary infections 
Prevention of UTI is therefore one of the most important tools in the treatment of 
catheterized subjects. The procedure of catheterization has to be done in order to avoid 
contamination of the intra or extra lumen drainage system. In accordance with the 2009 
guidelines of the English Department of Health to prevent urinary tract infections in 
catheterized subjects, it is well know that closed drainage is infection free for the first 15 
days and that after this period bacteria begin to spread in the bladder. In this context it 
seems that there are no differences in the infection rate between short-term sterile and short-
term clean catheterization techniques based on recent literature reviews(31,32). The first 
review compared sterile catheterization with clean catheterization. No difference was shown 
between the two groups of patients, even if the sample was too limited to show any possible 
differences. The second review based on 436 women in labor compared genital cleaning 
before catheterization using chlorhexidine with the one using tap water alone showing also 
in this case no significant differences. The conclusion was that antiseptics do not reduce the 
bacteriuria rate. On the contrary open catheter drainage systems lead to bacteriuria in 
virtually all patients in few days, and this system is not recommended. (Grade of 
recommendation: A)(33).  
Since as biofilm is the central factor in the pathogenesis of CAUTI, strategies designed to 
prevent biofilm formation with novel catheter material or coating are currently being 
investigated as shown in randomized trials reporting antimicrobial-impregnated catheters 
containing either nitrofurazone (34) or the combination of the broad-spectrum antibiotics 
minocycline and rifampin (35). This report demonstrated significant reductions in bacterial 
CAUTIs even if these results need further confirmations. In this way the advantage from the 
use of coated urinary catheters is not clear. In fact clinical trials have shown conflicting 
results as to the efficacy of silver oxide-coated catheters compared with uncoated catheters. 
In a prospective clinical trial involving hospitalized patients, silver oxide-coated catheters 
reduced the incidence of UTI only among women without antimicrobial agents 
administration compared with a control silicone catheter (36). A randomized study of 1,309 
patients catheterized longer than 24h failed to demonstrate the effectiveness of a silicone 
catheter coated externally with silver oxide compared to a standard silicone coated latex 
catheter. However, these silver oxide catheters showed a significantly increased incidence of 
bacteriuria (37). With regard to this, literature on silver alloy latex catheters has failed to 
resolve the controversy over their efficacy and at present there is insufficient evidence to 
recommend the use of silver alloy catheters (Grade of recommendation: B)(33). Therefore it 
is evident that the use of indwelling urinary catheters, due to their complications, should be 
strictly related to specific and inalienable clinical conditions. Current data do not support 
the treatment of asymptomatic bacteriuria, either during short-term catheterization or 
during long-term catheterization, because it will promote the emergence of resistant strains 
(33). In short-term catheterization, antibiotics may delay the onset of bacteriuria, but do not 
www.intechopen.com
 Catheters and Infections 
 
93 
reduce complications (33). A symptomatic complicated UTI associated with an indwelling 
catheter is treated with an agent with as narrow a spectrum as possible, based on culture 
and sensitivity results. The optimal duration is not well established. Treatment durations 
that are both too short as well as too long may cause the emergence of resistant strains. A 7-
day course may be a reasonable compromise (33).  
Finally in case of treatment of fungal urinary tract infection we know that it is recommended 
only when funguria is symptomatic or in cases of fungal colonization when host factors 
increase the risk of fungemia. The antifungal agents used for funguria are mainly 
fluconazole and amphotericin B deoxycholate, because other drugs have extremely low 
concentrations in urine. Intravesical amphotericin B and oral fluconazole therapy are each 
effective in treatment of funguria (28).  
10. Antibiotic prophylaxis and invasive urodynamics in female 
Invasive urodynamics involving catheterization of the lower urinary tract is an essential 
part in the evaluation of detrusor filling and voiding phase in patients needing assessment 
of bladder function(1).  
Urinary tract infections (UTI) are a recognized complication of urodynamic study. The 
natural history of bacteriuria after urodynamics is not completely known. The overall 
incidence of bacteriuria after urodynamic studies is not yet clear. In fact bacteriuria occurs in 
1-5% of hospitalized patients after single short-term catheterization and in ambulatory ones 
lower than 1%. After cystometry, the reported incidence of bacteriuria varies from 1.5% to 
30%, showing that the incidence of UTI in patients who underwent invasive urodynamics is 
present in most cases (2,3). In this context, the opinions on the safety of urodynamic studies 
differ among the authors. At present, published data on prophylaxis in urodynamics have 
showed contradictory results with a limited predictive value. Some investigators concluded 
that antibiotic prophylaxis seems to reduce the incidence of urinary tract infections and to 
protect patients from the risk of bacterial contamination from urethral catheterization, 
especially for those with high risk of infection(4). In this setting it was reported an overall 
infection rate of 15%, so concluding that antibiotic prophylaxis should be considered(5). 
Subsequently other authors reported that after invasive urodynamics the patients had UTI 
in 4% of cases, recommending the use of antibiotic before the procedure(4). In this way 
others reported an incidence of significant bacteriuria in less than of 1% of patients with 
antibiotic prophylaxis, so this approach is considered useful (6,). Similarly it was described 
that invasive urodynamics in postmenopausal female subjects are safe procedures without 
the necessity to perform it(1).  
Antimicrobial prophylaxis entails treatment with an antimicrobial agent before and for a 
limited time after a procedure to prevent local or systemic postprocedural infections. For 
most procedures, prophylaxis should be initiated between 30 minutes and 120 minutes 
before the procedure. Efficacious levels should be maintained for the duration of the 
procedure and, in special circumstances, a limited time (24 hours, at most) after the 
procedure(7).  
In this scenario several conditions are associated with a major risk of UTI with particular 
regard to women. In this setting many studies have revealed that for women presenting 
urogynecologic units to undergo an invasive urodynamic examination, there is a relatevely 
low incidence of bacteriuria (8%) after few days(8,9). Other series of a comparable number of 
women have shown incidences ranging from 1.6% to 17%(3). These discrepancies may be due 
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to variability in age of patients, kwowing well that advancing age is associated with a higher 
rate of UTI, or with different catheterization techniques (the trauma caused by 
catheterization itself may leave the lower urinary tract more susceptible to a later 
infection)(10). Recently it showed that the low vascularization of soft tissues in bladder and 
urethra in postmenopausal female is associated with a higher risk of UTI perhaps because 
this condition could delay or prevent the effect of an antibiotic prophylactic drug, which 
probably cannot reach these tissues in an adequate manner and concentration(11). 
Recently some authors revealed that in postmenopausal women there is a slightly higher 
incidence rate of UTI after invasive urodynamics compared to the studies previously 
published in literature and this trend is not affected by the administration of an antibiotic 
prophylaxis. Urodynamic testing however remains a safe investigative procedure with low 
morbidity and infection rate in postmenopausal women when performed by sterile 
catheterization, even without any antibiotic prophylaxis(5).  
In conclusion, we could stop administering antibiotic prophylaxis to postmenopausal 
patients undergoing invasive urodynamics 
11. Conclusions 
Urinary tract infections represent the second most often observed infectious diseases in 
community, following the respiratory tract infections. In nosocomial setting, UTIs represent 
the most frequent diseases, whose incidence equates 40% of nosocomial infections overall 
considered; about 80% of UTIs is related to urinary catheterization. Therefore it is strongly 
suggested the opportunity to increase any prevention strategy able to reduce the incidence 
of infections related to urinary catheterization and its consequences, as a more rational 
length and modality of catheterization, in addition to the use of innovative catheters: 
recently the use of newborn materials, such as antibiotic-impregnated catheters or silver-
coated ones has started. By now, though, there was not enough evidence to suggest whether 
or not any standard catheter was better than another in terms of reducing the risk of urinary 
tract infection in hospitalised adults catheterised short-term. Siliconised catheters may be 
less likely to cause urethral side effects however, these results should be interpreted with 
some caution as the trials were small and the outcomes are still under investigation. 
12. Appendix: standard catheterization procedure 
1. Gather equipment. 
2. Explain procedure to the patient. 
3. Assist patient into supine position with legs spread and feet together. 
4. Open catheterization kit and catheter. 
5. Prepare sterile field, apply sterile gloves. 
6. Check balloon for patency. 
7. Generously coat the distal portion (2-5 cm) of the catheter with lubricant. 
8. Apply sterile drape. 
9. If female, separate labia using non-dominant hand. If male, hold the penis with the non-
dominant hand. Maintain hand position until preparing to inflate balloon. 
10. Using dominant hand to handle forceps, cleanse peri-urethral mucosa with cleansing 
solution. Cleanse anterior to posterior, inner to outer, one swipe per swab, discard swab 
away from sterile field. 
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11. Pick up catheter with gloved (and still sterile) dominant hand. Hold end of catheter 
loosely coiled in palm of dominant hand. 
12. In the male, lift the penis to a position perpendicular to patient's body and apply light 
upward traction (with non-dominant hand). 
13. Identify the urinary meatus and gently insert until 1 to 2 inches beyond where urine is 
noted. 
14. Inflate balloon, using correct amount of sterile liquid (usually 10 cc but check actual 
balloon size). 
15. Gently pull catheter until inflation balloon is snug against bladder neck. 
16. Connect catheter to drainage system. 
17. Secure catheter to abdomen or thigh, without tension on tubing. 
18. Place drainage bag below level of bladder. 
19. Evaluate catheter function and amount, color, odor, and quality of urine. 
20. Remove gloves, dispose of equipment appropriately, wash hands. 
21. Document size of catheter inserted, amount of water in balloon, patient's response  to 
procedure, and assessment of urine 
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